- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2008
- Public Summary Document (PSD) November 2008 PBAC Meeting - PDF
Lanthanum carbonate hydrate – November 2008
Lanthanum carbonate hydrate, chewable tablet, 500 mg, 750 mg and 1000 mg, Fosrenol®, Shire Australia Pty Ltd, November 2008
Last updated
25 March 2009
